Area of research
Molecular Biology · Hematology
Research interest
Research interests include Multiple Myeloma Research and Treatments, Genomics and Phylogenetic Studies, Microbial Community Ecology and Physiology, and Protein Degradation and Inhibitors.
Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma
<i>In Vitro</i> and <i>In Vivo</i> Antitumor Activity of a Novel Alkylating Agent, Melphalan-Flufenamide, against Multiple Myeloma Cells
Lenalidomide for the treatment of relapsed and refractory multiple myeloma